goat antibodies against mouse c3 (Valiant Co Ltd)
94
Structured Review
Valiant Co Ltd
goat antibodies against mouse c3
Goat Antibodies Against Mouse C3, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 117 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+complement+c3/Anti-mouse+Complement+C3+goat+antiserum/pmc13088890-165-19-24
Average 94 stars, based on 117 article reviews
Goat Antibodies Against Mouse C3, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 117 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+complement+c3/Anti-mouse+Complement+C3+goat+antiserum/pmc13088890-165-19-24
Average 94 stars, based on 117 article reviews
goat antibodies against mouse c3 - by Bioz Stars,
2026-11
94/100 stars
Images
1) Product Images from "Yersinia enterocolitica O:3 Outer Membrane Vesicles as a Platform for Complement Activation"
Article Title: Yersinia enterocolitica O:3 Outer Membrane Vesicles as a Platform for Complement Activation
Journal: Journal of Extracellular Vesicles
doi: 10.1002/jev2.70270
Figure Legend Snippet: (A) The impact of OMVs on germicidal activity of serum against YeO3‐c bacteria. The influence of OMVs‐associated with: LPS polysaccharide chain length (a) and pYV‐coded factors (b). Data from one of at least two experiments with the use of separately prepared culture supernatants with similar results are presented. 1 sterile cell culture supernatants (secreted by bacteria grown to OD 600 = 0.6) were used as a source of OMVs; 2 expression at 37°C only; 3 NHS inactivated 30 min at 56°C. (B) Y. enterocolitica O:3 OMV‐induced complement activation in the presence of calcium and magnesium chelators. ELISA plates were coated with 10 8 of OMVs secreted by YeS‐c bacteria grown at 4°C, 22°C and 37°C and with OMVs of YeRa‐c, YeRd1‐c and YeRe‐c variants propagated at 37°C. After incubation with/without EDTA, EGTA or EGTA/Mg 2+ (EGTA supplemented with Mg 2+ ions), products of C3 activation were detected with specific antibodies. Data from one of two experiments with similar results are presented. (C) Comparison of complement activation and MBL binding by Yersinia enterocolitica O:3 bacterial cells, LPS and OMVs. ELISA plates were coated with 50 ng/well of bacteria, LPS or OMVs. The deposition of C3 (a, possible AP, CP and LP involvement), C4 (b, possible CP and LP involvement) or C4 LP‐dependent (d) activation products, TCC formation (c, possible AP, CP and LP involvement) and MBL‐binding (e) was analyzed after preincubation with normal human serum (filled columns) or with EDTA‐treated NHS (stripped columns) or without serum (open columns, negative control). Data from one of two experiments with similar results are presented. Dots represent individual OD values for each well. (D) Recognition of Y. enterocolitica O:3 OMVs by human mannose‐binding lectin. YeS‐c_37°C bacteria (1), OMVs (2) and LPS (3) were separated in SDS‐PAGE. After transfer to nitrocellulose and incubation with NHS, the bound MBL was detected with specific mAb (a). The experiment was performed at least 5 times. To control the loading of bacteria, LPS or OMVs the presence of OPS in separated samples was confirmed with anti‐6‐deoxy‐L‐altropyranose mAbs (b).
Techniques Used: Activity Assay, Bacteria, Sterility, Cell Culture, Expressing, Activation Assay, Enzyme-linked Immunosorbent Assay, Incubation, Comparison, Binding Assay, Negative Control, SDS Page, Control
Related Articles
Control:Article Title: Annexin A2 interferes with complement regulation within the glomerulus Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Article Title: Annexin A2 interferes with complement regulation within the glomerulus. Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Article Title: Annexin A2 interferes with complement regulation within the glomerulus. Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Labeling:Article Title: Annexin A2 interferes with complement regulation within the glomerulus Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Article Title: Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Article Snippet: Effective inhibition of the complement system is needed to prevent the accelerated clearance of nanomaterials by complement cascade and inflammatory responses.. Here we show that a fusion construct consisting of human complement receptor 2 (CR2) (which recognizes nanosurface-deposited complement 3 (C3)) and complement receptor 1 (CR1) (which blocks C3 convertases) inhibits complement activation with picomolar to low nanomolar efficacy on many types of nanomaterial.. We demonstrate that only a small percentage of nanoparticles are randomly opsonized with C3 both in vitro and in vivo, and CR2-CR1 immediately homes in on this subpopulation. Article Title: Annexin A2 interferes with complement regulation within the glomerulus. Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Article Title: Annexin A2 interferes with complement regulation within the glomerulus. Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Tissue:Article Title: Annexin A2 interferes with complement regulation within the glomerulus Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Staining:Article Title: Annexin A2 interferes with complement regulation within the glomerulus Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Article Title: Annexin A2 interferes with complement regulation within the glomerulus. Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Article Title: Annexin A2 interferes with complement regulation within the glomerulus. Article Snippet: .. Antibodies used in the experiments included a rabbit polyclonal antibody to human annexin A2 (Proteintech; #11256-1-AP, 1:250 dilution), IgG1 monoclonal anti-AnxA2 clone Z014 (Invitrogen; #034400, 2 μg per sample), IgG1 isotype control clone MG1-45 (Abcam; # ab18448, 2 μg per sample), a Cy3-conjugated polyclonal goat anti-mouse IgG (Jackson Immuno; 1:100 dilution), an Alexa Fluor Plus 647 labeled goat anti-mouse IgG (Invitrogen; #A32728, 1:1000 dilution), a FITC-labeled goat polyclonal antibody to Article Title: Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3G Article Snippet: .. C3 was detected by staining sections with a Chromatin Immunoprecipitation:Article Title: Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Article Snippet: Effective inhibition of the complement system is needed to prevent the accelerated clearance of nanomaterials by complement cascade and inflammatory responses.. Here we show that a fusion construct consisting of human complement receptor 2 (CR2) (which recognizes nanosurface-deposited complement 3 (C3)) and complement receptor 1 (CR1) (which blocks C3 convertases) inhibits complement activation with picomolar to low nanomolar efficacy on many types of nanomaterial.. We demonstrate that only a small percentage of nanoparticles are randomly opsonized with C3 both in vitro and in vivo, and CR2-CR1 immediately homes in on this subpopulation. Flow Cytometry:Article Title: Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Article Snippet: Effective inhibition of the complement system is needed to prevent the accelerated clearance of nanomaterials by complement cascade and inflammatory responses.. Here we show that a fusion construct consisting of human complement receptor 2 (CR2) (which recognizes nanosurface-deposited complement 3 (C3)) and complement receptor 1 (CR1) (which blocks C3 convertases) inhibits complement activation with picomolar to low nanomolar efficacy on many types of nanomaterial.. We demonstrate that only a small percentage of nanoparticles are randomly opsonized with C3 both in vitro and in vivo, and CR2-CR1 immediately homes in on this subpopulation. Magnetic Resonance Imaging:Article Title: Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Article Snippet: Effective inhibition of the complement system is needed to prevent the accelerated clearance of nanomaterials by complement cascade and inflammatory responses.. Here we show that a fusion construct consisting of human complement receptor 2 (CR2) (which recognizes nanosurface-deposited complement 3 (C3)) and complement receptor 1 (CR1) (which blocks C3 convertases) inhibits complement activation with picomolar to low nanomolar efficacy on many types of nanomaterial.. We demonstrate that only a small percentage of nanoparticles are randomly opsonized with C3 both in vitro and in vivo, and CR2-CR1 immediately homes in on this subpopulation. Incubation:Article Title: Eosinophil-derived neurotoxin and eosinophil cationic protein are key molecules for blister formation in bullous pemphigoid. Article Snippet: Abbreviations used BP: Bullous pemphigoid BP-IgG: IgG from patients with BP COL17: Type XVII collagen DEJ: Dermal-epidermal junction DIF: Direct immunofluorescence ECP: Eosinophil cationic protein EDN: Eosinophil-derived neurotoxin IIF: Indirect immunofluorescence MBP: Major basic protein MPO: Myeloperoxidase NC16A: Noncollagenous 16A OD: Optical density Tbx21: T-box transcription factor 21 WT: Wild type Background: Eosinophils, which are multifunctional leukocytes, play pivotal roles in tissue repair, immune responses against pathogens, and the pathogenesis of various diseases, including neoplasms and inflammatory conditions such as asthma and atopic dermatitis.. Despite advancements in understanding eosinophil biology and recruitment, the specific roles of eosinophil granule proteins in eosinophil-associated autoimmune diseases remain incompletely understood.. Objective: We sought to investigate the role of eosinophils in the pathogenesis of autoimmune blistering dermatoses. Functional Assay:Article Title: Yersinia enterocolitica O:3 Outer Membrane Vesicles as a Platform for Complement Activation Article Snippet: Mice were treated i.p . with 3.5 U of Naja naja kaouthia cobra venom factor (CVF) (Quidel, USA) in 100 μL of PBS at 28, 24, and 4 h before injection of YeS_37°C OMVs. .. Depletion of functional C3 from serum was verified in Western blot [acc. to Younger et al. ( )], using Western Blot:Article Title: Yersinia enterocolitica O:3 Outer Membrane Vesicles as a Platform for Complement Activation Article Snippet: Mice were treated i.p . with 3.5 U of Naja naja kaouthia cobra venom factor (CVF) (Quidel, USA) in 100 μL of PBS at 28, 24, and 4 h before injection of YeS_37°C OMVs. .. Depletion of functional C3 from serum was verified in Western blot [acc. to Younger et al. ( )], using |
